AGP Executive Report
Last update: 2 hours agoFederal Cannabis Policy: A DEA rescheduling hearing wrapped up in Washington, with a judge ordering post-hearing briefs due Aug. 17 and no clear deadline for the final recommendation—meaning Michigan and Ohio businesses could face a long wait even if Schedule III changes move forward. Hemp Retail Legal Fight: A coalition of hemp businesses sued to block Missouri’s ban on intoxicating hemp products, arguing the law’s definitions are “unconstitutionally vague” and would pull THC seltzers from shelves starting Nov. 12. Record Clearing & Social Equity: Minnesota’s Cannabis Expungement Board is ramping outreach, including a clinic in North Minneapolis, to vacate eligible felony convictions without residents needing an attorney. Local Market Growth: Guam issued its first recreational cannabis cultivation license, while the U.S. Virgin Islands opened cannabis license applications with a Sept. 15 deadline. Product & Research: Leiutis Pharmaceuticals says India’s CDSCO approved a synthetic CBD oral solution for anxiety disorders (with CBT), and a new study claims THC and CBD may help treat agitation in dementia patients. Industry Politics: Major marijuana companies donated $11.5M to a Trump-linked agriculture PAC, per updated federal filings.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
